D.A. Davidson & Co’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$811K Sell
1,713
-682
-28% -$343K ﹤0.01% 990
2025
Q4
$1.12M Buy
2,395
+388
+19% +$180K 0.01% 853
2025
Q3
$855K Sell
2,007
-356
-15% -$138K 0.01% 932
2025
Q2
$905K Sell
2,363
-1,293
-35% -$466K 0.01% 843
2025
Q1
$1.26M Buy
3,656
+931
+34% +$299K 0.01% 696
2024
Q4
$818K Sell
2,725
-1,317
-33% -$460K 0.01% 839
2024
Q3
$1.64M Buy
4,042
+1,536
+61% +$562K 0.01% 616
2024
Q2
$805K Sell
2,506
-1,602
-39% -$521K 0.01% 806
2024
Q1
$1.37M Sell
4,108
-292
-7% -$89.2K 0.01% 630
2023
Q4
$1.19M Sell
4,400
-1,151
-21% -$284K 0.01% 652
2023
Q3
$1.37M Buy
5,551
+374
+7% +$102K 0.01% 584
2023
Q2
$1.57M Buy
5,177
+1,868
+56% +$519K 0.02% 557
2023
Q1
$873K Buy
+3,309
New +$841K 0.01% 729
2019
Q2
Sell
-2,836
Closed -$368K 1065
2019
Q1
$368K Sell
2,836
-165
-5% -$22.2K 0.01% 788
2018
Q4
$373K Sell
3,001
-460
-13% -$61.7K 0.01% 740
2018
Q3
$481K Sell
3,461
-107
-3% -$13.3K 0.01% 723
2018
Q2
$366K Buy
3,568
+201
+6% +$20.3K 0.01% 808
2018
Q1
$327K Sell
3,367
-136
-4% -$13.2K 0.01% 835
2017
Q4
$308K Buy
+3,503
New +$281K 0.01% 837
2017
Q3
Sell
-1,970
Closed -$171K 1468
2017
Q2
$171K Buy
1,970
+539
+38% +$45.6K ﹤0.01% 1026
2017
Q1
$127K Buy
1,431
+1,045
+271% +$87.1K ﹤0.01% 1137
2016
Q4
$26K Buy
386
+6
+2% +$449 ﹤0.01% 1844
2016
Q3
$27K Buy
380
+124
+48% +$9.49K ﹤0.01% 1759
2016
Q2
$18K Buy
256
+54
+27% +$4.26K ﹤0.01% 1796
2016
Q1
$15K Buy
202
+6
+3% +$419 ﹤0.01% 1801
2015
Q4
$12K Sell
196
-289
-60% -$20.2K ﹤0.01% 1859
2015
Q3
$36K Sell
485
-205
-30% -$18.2K ﹤0.01% 1492
2015
Q2
$60K Buy
690
+425
+160% +$34K ﹤0.01% 1350
2015
Q1
$19K Buy
+265
New +$19K ﹤0.01% 1671
2014
Q4
Sell
-50
Closed -$3K 2120
2014
Q3
$3K Hold
50
﹤0.01% 1994
2014
Q2
$2K Hold
50
﹤0.01% 2036
2014
Q1
$2K Hold
50
﹤0.01% 2031
2013
Q4
$2K Buy
+50
New +$2.31K ﹤0.01% 1970

Other funds holding HCA

D.A. Davidson & Co's HCA Position: Q1 2026 in Review

D.A. Davidson & Co reduced its HCA Healthcare (HCA) stake by 28% in Q1 2026, selling an estimated $343K and leaving 1,713 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #990.

D.A. Davidson & Co first reported a position in HCA in Q4 2013 and has held it in 33 quarters since. The position peaked at $1.64M in Q3 2024. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • D.A. Davidson & Co held 1,713 shares of HCA Healthcare worth $811K as of Q1 2026.
  • D.A. Davidson & Co sold 682 HCA Healthcare shares in Q1 2026, an estimated $343K.
  • HCA Healthcare made up ﹤0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #990 holding.
  • D.A. Davidson & Co first reported a position in HCA Healthcare in Q4 2013 and has held it in 33 quarters since.
  • D.A. Davidson & Co's HCA Healthcare position peaked at $1.64M in Q3 2024.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.